Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

In vitro model of human subcutaneous adipocyte spheroids for studying mitochondrial dysfunction and mitochondria activating compounds

Title: In vitro model of human subcutaneous adipocyte spheroids for studying mitochondrial dysfunction and mitochondria activating compounds
Authors: Anita Wagner; Juulia H. Lautaoja-Kivipelto; Kalle Pehkonen; Antti Hassinen; Minna Kuusela; Lisa Röttger; Elena Herbers; Anna Ioannidou; Sophia Mädler; Ina Rothenaigner; Soumya Srinivasan; Sini Laasonen; M. Tanvir Rahman; Pinja Elomaa; Saija Kortetjärvi; Anneli Olsson; Olavi Ukkola; Kamyar Hadian; Matthias Mann; Hilkka Peltoniemi; Kirsi H. Pietiläinen; Martin Klingenspor; Kirsi A. Virtanen; Carolina E. Hagberg; Eija Pirinen
Source: iScience, Vol 29, Iss 2, Pp 114480- (2026)
Publisher Information: Elsevier
Publication Year: 2026
Collection: Directory of Open Access Journals: DOAJ Articles
Subject Terms: Lipid; Human metabolism; Adipocyte; Mitochondria; Spheroid; Obesity; Science
Description: Summary: Mitochondrial abnormalities drive subcutaneous white adipose tissue dysfunction in obesity, yet in vitro models to study adipocyte mitochondria remain limited. Here, we establish a human subcutaneous adipocyte spheroid model to characterize mitochondrial metabolism under obesity-relevant conditions and drug exposure. Human preadipocyte spheroids were differentiated in ultra-low attachment plates for 3 weeks using thiazolidinedione-free medium. Matrigel embedding was incorporated into the protocol as it promoted mitochondrial network and respiration compared to scaffold-free conditions. Differentiated spheroids showed increased lipid accumulation, adipogenic gene expression, mitochondrial respiration, adiponectin secretion, and hormonal responsiveness. Lipid mixture administration during differentiation induced metabolic disturbances, including mitochondrial respiration failure, alongside increased mitochondrial biogenesis. Post-differentiation treatment with rosiglitazone, a peroxisome proliferator-activated receptor γ agonist, improved mitochondrial bioenergetics and adiponectin secretion in lipid mixture-administered adipocyte spheroids. Our model enables precise measurement of adipocyte mitochondria metabolism, providing a platform for mitochondria-focused research and drug discovery in obesity.
Document Type: article in journal/newspaper
Language: English
Relation: http://www.sciencedirect.com/science/article/pii/S2589004225027415; https://doaj.org/toc/2589-0042; https://doaj.org/article/f8a153789784490d92cf1ce6501fbf68
DOI: 10.1016/j.isci.2025.114480
Availability: https://doi.org/10.1016/j.isci.2025.114480; https://doaj.org/article/f8a153789784490d92cf1ce6501fbf68
Accession Number: edsbas.94EE63CA
Database: BASE